Agilent Technologies Inc (A) Position Reduced by MUFG Americas Holdings Corp

MUFG Americas Holdings Corp decreased its position in shares of Agilent Technologies Inc (NYSE:A) by 24.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,759 shares of the medical research company’s stock after selling 1,512 shares during the period. MUFG Americas Holdings Corp’s holdings in Agilent Technologies were worth $336,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. SRS Capital Advisors Inc. increased its holdings in shares of Agilent Technologies by 75.9% in the second quarter. SRS Capital Advisors Inc. now owns 1,791 shares of the medical research company’s stock valued at $110,000 after buying an additional 773 shares in the last quarter. Moneta Group Investment Advisors LLC increased its holdings in shares of Agilent Technologies by 391.7% in the second quarter. Moneta Group Investment Advisors LLC now owns 6,023 shares of the medical research company’s stock valued at $158,000 after buying an additional 4,798 shares in the last quarter. TRUE Private Wealth Advisors bought a new position in shares of Agilent Technologies in the third quarter valued at $181,000. AMG National Trust Bank bought a new position in shares of Agilent Technologies in the third quarter valued at $212,000. Finally, UMB Bank N A MO bought a new position in shares of Agilent Technologies in the third quarter valued at $219,000.

Shares of NYSE:A opened at $69.36 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29. Agilent Technologies Inc has a 12-month low of $60.42 and a 12-month high of $75.11. The firm has a market cap of $22.11 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 1.94 and a beta of 1.36.

Agilent Technologies (NYSE:A) last announced its earnings results on Monday, November 19th. The medical research company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.07. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the previous year, the business earned $0.67 EPS. The company’s revenue was up 8.8% on a year-over-year basis. On average, sell-side analysts forecast that Agilent Technologies Inc will post 3.04 earnings per share for the current fiscal year.

Agilent Technologies announced that its Board of Directors has initiated a stock repurchase plan on Monday, November 19th that permits the company to buyback $1.75 billion in outstanding shares. This buyback authorization permits the medical research company to repurchase up to 8.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be paid a dividend of $0.164 per share. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend is Friday, December 28th. Agilent Technologies’s payout ratio is 21.51%.

In other Agilent Technologies news, insider Dominique Grau sold 8,902 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $74.00, for a total transaction of $658,748.00. Following the sale, the insider now directly owns 103,387 shares of the company’s stock, valued at approximately $7,650,638. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Rodney Gonsalves sold 1,500 shares of the business’s stock in a transaction on Wednesday, November 28th. The shares were sold at an average price of $71.06, for a total transaction of $106,590.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 26,325 shares of company stock worth $1,930,902.

Several research analysts have issued reports on the company. Morgan Stanley upped their price target on Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a report on Wednesday, October 10th. ValuEngine raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday, September 13th. Goldman Sachs Group reaffirmed a “buy” rating and issued a $82.00 price target (up previously from $77.00) on shares of Agilent Technologies in a report on Tuesday, September 18th. Zacks Investment Research cut Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 16th. Finally, Cleveland Research cut Agilent Technologies from a “buy” rating to a “neutral” rating in a report on Monday, November 12th. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $78.75.

ILLEGAL ACTIVITY WARNING: “Agilent Technologies Inc (A) Position Reduced by MUFG Americas Holdings Corp” was originally published by WKRB News and is owned by of WKRB News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.wkrb13.com/2018/12/16/agilent-technologies-inc-a-position-reduced-by-mufg-americas-holdings-corp.html.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Featured Article: S&P 500 Index

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply